News

Godavari Drugs announced that the 38th Annual General Meeting(AGM) of the company will be held on 25 September 2026.

Net profit of Godavari Drugs rose 44.94% to Rs 1.29 crore in the quarter ended March 2026 as against Rs 0.89 crore during the previous quarter ended March 2025. Sales rose 30.04% to Rs 33.16 crore in the quarter ended March 2026 as against Rs 25.50 crore during the previous quarter ended March 2025.For the full year,net profit declined 6.62% to Rs 4.09 crore in the year ended March 2026 as against Rs 4.38 crore during the previous year ended March 2025. Sales declined 6.65% to Rs 105.81 crore in the year ended March 2026 as against Rs 113.35 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales33.1625.50 30 105.81113.35 -7 OPM %8.8712.20 -9.7410.44 - PBDT2.132.11 1 7.138.08 -12 PBT1.521.44 6 4.705.63 -17 NP1.290.89 45 4.094.38 -7 Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 27 May 2026.

Net profit of Godavari Drugs declined 1.30% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 24.94% to Rs 22.18 crore in the quarter ended December 2025 as against Rs 29.55 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales22.1829.55 -25 OPM %11.148.70 - PBDT1.381.56 -12 PBT0.770.92 -16 NP0.760.77 -1 Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News